Cargando…
Radioembolization for hepatocellular carcinoma: what clinicians need to know
Transarterial radioembolization (TARE) with yttrium 90 ((90)Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea. There are two types of (90)Y radioactive microspheres available, namely, glass and resin microspheres, with comparable clinical outcomes....
Autores principales: | Choi, Jin Woo, Kim, Hyo-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Liver Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035707/ https://www.ncbi.nlm.nih.gov/pubmed/37383534 http://dx.doi.org/10.17998/jlc.2022.01.16 |
Ejemplares similares
-
Radioembolization for the treatment of hepatocellular carcinoma
por: Kim, Hyo-Cheol
Publicado: (2017) -
Lung shunt fraction quantification methods in radioembolization: What you need to know
por: Torkian, Pooya, et al.
Publicado: (2022) -
Imaging Evaluation Following (90)Y Radioembolization of Liver Tumors: What Radiologists Should Know
por: Joo, Ijin, et al.
Publicado: (2018) -
Chyluria: what does the clinician need to know?
por: Stainer, Victoria, et al.
Publicado: (2020) -
Urate Transporters in the Kidney: What Clinicians Need to Know
por: Chung, Sungjin, et al.
Publicado: (2021)